 This is a Non-randomized, prospective, non-interventional multi-center post-market release PMR study. Up to 800 subjects will be enrolled at up to 40 centers in Europe. After aortic valve replacement with the Enable aortic bioprosthesis, each patient will have routine follow-up visits at the following intervals: at 30 days post-implant at 30 days post-implant or prior to hospital discharge, whatever comes first, within 6 months following implantation, 1 year and annually thereafter up to 5 years post-implant. 